Is the Monoclone Ant Body a Good Choice for Inpatients?

The monoclone ant bodies have been a moving target, because it seems like the efficacy changes with the variant. And then there's two drugs, which the generic names are pretty much unpronounceable. I don't think the oil anovils are going to have a place in the inpatient setting in the seeable future. But some potential studies coming down that may look at combination therapy, or alternative therapy could shift that paradime further down the road.